Objective To detect if removing the cervical mucus before performing intrauterine insemination (IUI) could improve pregnancy outcomes in patients with unexplained infertility.
Introduction
When planning treatment for infertile couples, consideration should be given to optimizing the pre-fertilization factors to reduce the health risks that may be encountered with ovarian stimulation protocols as well as the total treatment costs. 1 Before shifting to invasive and expensive fertility procedures, the physician should always provide couples with treatment options that may achieve higher success rates than ordinary intercourse and demand less costly monitoring. 2 Intrauterine insemination (IUI) is the simplest form of assisted reproduction as it is easily manipulated, relatively inexpensive, and can be performed in low-resource clinics. 3 The procedure can be effective in a variety of cases including mild male-factor infertility, cervical-mucus hostility, unexplained infertility, and some immunologic abnormalities. 4 Pregnancy rates following IUI are generally in the 5-30% range, depending upon multiple factors such as cause of infertility, quantity and quality of sperm, and presence of healthy fallopian tubes as well as properly functioning ovaries. 5 When relating IUI success rates to infertility causes, better results are achieved with unexplained infertility, Trial registration number: ISRCTN87670645 (www.isrctn.com/ ISRCTN87670645). cervical factors, and mild male-factor infertility, 6 Research into improving results for these indications is therefore continuing.
Cervical mucus is one of the factors that play a role in natural fertilization, being the site for sperm capacitation, but it may also be the cause of infertility when it harbours antisperm antibodies. 7 While IUI can avoid cervical mucus and its undesirable properties, some of its effects may still be present. Simsek et al. 8 stated that, when hostile cervical mucus is introduced into the endometrial cavity by the insemination catheter, sperm motility may be decreased, reducing or even preventing sperm-oocyte interaction, with negative effects on pregnancy outcomes.
For women treated by in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI), cervical mucus removal prior to embryo transfer is associated with higher pregnancy rates, 9 but its value in IUI has not been studied in any randomized trial.
The objective of this study was to detect if removing the cervical mucus before performing IUI could improve pregnancy outcomes in patients with unexplained infertility.
Methods
A prospective randomized semi-blinded trial conducted at the Department of Obstetrics and Gynaecology, Menoufia University Hospitals, Shebin El-Kom, Egypt. The study was approved by the hospital ethics committee and registered with the International Standard Randomised Controlled Trial Number ISRCTN87670645. The study design was explained to all patients who provided their consent before being involved in the trial. The first patient was enrolled in November 2014, and the last patient delivered in March 2017. The CONSORT guidelines were followed throughout the study.
Women aged 35 years or under with a diagnosis of unexplained infertility (primary type) were eligible for the study, with older patients also included after counselling that fertility drops by more than 50% after age 35 and with a body mass index of under 30 kg/m 2 . The diagnosis of unexplained infertility was made according to the following: normal semen analysis based on World Health Organization criteria; 10 day two transvaginal scan and hormonal profile within normal range (total antral follicle count of 10-24, follicular stimulating hormone (FSH) <10 IU/ml, and serum prolactin ≤20 ng/ml); normal thyroid function; normal uterine cavity on hysterosalpingography or hysteroscopy; and patent tubes on hysterosalpingography or laparoscopy.
Exclusion criteria included diminished ovarian reserve (basal FSH level >10 IU/ml, total antral follicle count <10, or anti-M€ ullerian hormone, if done, <0.7 ng/ml), resistant ovarian cyst (>20 mm for >1 month), and previous IUI attempts. Cycle cancellation was attempted if more than two follicles appeared and these couples offered timed intercourse. Although there is no ovulation induction protocol that avoids the risk of multiple pregnancies, the higher the number of follicles, the higher the risk. 11 We attempted to reduce this risk by adhering to a more conservative gonadotropin-stimulation protocol and withholding human chorionic gonadotropin (hCG) administration and insemination if more than two dominant follicles appeared.
Participants were randomized by a statistician who generated a trial sequence by computer. The sequence was concealed in opaque envelopes. Patients were blinded regarding the group assignment, but not the assisting nurses or doctors.
Each couple in the study was involved for one cycle. If no pregnancy resulted, treatment could be continued outside the study protocol.
Ovarian stimulation started on day three to day five of the patient's cycle using highly purified human menopausal gonadotropin (hMG) (Menogon â , Ferring, Switzerland) with an initial dose of 150 IU for five days (step-down protocol). For women at higher risk of ovarian hyperstimulation (female age <30 years, BMI <20, or previous history of ovarian hyperstimulation), however, a lower dose (75 IU) was used. Follicular response was assessed by ultrasound with adjustment of the hMG dose until one to two dominant follicles of 18 mm or more were detected. Serum estradiol level was measured at this time before triggering ovulation with hCG (Pregnyl â ; N.V. Organon, Oss, The Netherlands) 10 000 IU.
A single IUI was performed 36-40 hours following hCG injection. Patients were allocated into either the cervicalmucus-removal group (Group A) or the non-removal group (Group B). In Group A, an insemination catheter (Sperm Processor, Pvt. Ltd, Aurangabad, India) was used to remove cervical mucus from the cervical canal by passing the catheter repeatedly from internal to external os. A small cotton swab soaked with saline was then used to completely remove the cervical mucus. In Group B, only the external cervical os was cleaned with a small cotton swab soaked with saline. For both groups, a new insemination catheter (Sperm Processor, Pvt. Ltd) connected to a 2-ml syringe containing at least 1 ml prepared semen was gently passed through the cervical canal until it reached the uterine fundus and the semen slowly injected. Patients were instructed to remain supine for the next 15 minutes and to practice intercourse the following day.
As in a previous publication by one of the authors, 12 luteal phase support could improve pregnancy outcomes for patients having IUI, so it was our routine to start oncedaily progesterone vaginal suppositories (Cycologest 400 mg; Actavis, Ireland and NJ, USA) for 14 days from the day after insemination.
Serum b-hCG was checked 2 weeks after IUI; if positive, ultrasound was performed 2-4 weeks later to establish the presence of a gestational sac.
The primary outcome was the clinical pregnancy rate (defined as ultrasound evidence of pregnancy or products of conception identified by hisopathological examination) per patient.
Secondary outcomes were ongoing pregnancy rate (fetal heart pulsation beyond 20 weeks), live birth rate (live birth of at least one neonate surviving for at least 1 week after birth), miscarriage rate (no cardiac pulsation for a crown-rump length corresponding to 6 weeks or more, no crown-rump length in a gestational sac of 25 mm or more, or any pregnancy ended before 20 weeks), and multiple pregnancy rates (>1 gestational sac seen at 6 weeks).
Based on previous reports, 8, 13 we assumed that the clinical pregnancy rate in women who had their cervical mucus removed before IUI was 16% versus 9% for women who did not have this procedure. Accordingly, at a study power of 80% with an a-error of 0.05, a sample size of 714 cycles was needed for both groups.
Statistical analysis was done using SPSS version 20 (IBM, Armonk, NY, USA). Analyses were according to both the intention-to-treat and per-protocol principles. Qualitative data were expressed as percentages. v 2 or Fisher's exact tests were used as appropriate to test for differences. Quantitative data were examined using the Kolmogorov-Smirnov test to detect whether the data were normally distributed: if parametric, they were expressed as mean AE SD and the Student's t test was used; if non-parametric, the MannWhitney U test was used. The risk ratio (RR) with 95% confidence intervals (CI) was calculated using the MantelHaenszel method. P <0.05 was considered statistically significant.
Results
Our study included 714 couples who consented to participate. Cases were randomized into cervical-mucus-removal (361 patients) or non-cervical-mucus-removal (353 patients) groups. A total of 666 IUI cycles were completely followed up. A total of 25 cycles were cancelled because of multifollicular responses, while 23 cycles were lost in the follow-up. At the end of our study, therefore, 93.3% of all involved couples had provided full data for analyses as per protocol, but we also included the remaining 48 cycles (cancelled or lost) during the intention-to-treat analyses. The CONSORT statement flow chart for participants in the study is shown in Figure 1 .
Difficult catheterization was encountered in 17 cases (12 in the cervical-mucus-removal group and five in the nonmucus removal group). For all of these, re-insemination was done after full bladder to straighten the path and did not require the use of a tenaculum.
Demographic characteristics are shown in Table 1 . Both groups were comparable regarding female age, parity, body mass index, infertility duration, hormonal profile, post-processing total motile sperm count, and infertility duration (P >0.05).
The ovarian cycle parameters are shown in Table 2 . Between cycles, there were no significant differences in total hMG dose, number of days of stimulation, largest diameter of leading follicle, follicular response, endometrial thickness, and estradiol level at the time of triggering (P >0.05).
Reproductive outcomes according to intention-to-treat analysis are shown in Table 3 . Clinical pregnancy was recorded in 189 (26.5%) cases, of which 162 (85.7%) were singleton, while the remaining 27 (14.3%) were twins. The rates of clinical pregnancy, ongoing pregnancy, and live birth in the cervical-mucus-removal group were 31.0%, 27.1%, and 26.9%, respectively. When these rates were compared with corresponding rates in the non-mucusremoval group, significant differences were detected, with P-values of 0.005, 0.007, and 0.009, respectively. Both multiple pregnancy rates and miscarriage rates were comparable between groups.
According to the CONSORT guidelines for reporting of parallel group randomized controlled trials, it is recommended that both intention-to-treat and per-protocol analyses should be reported for all planned outcomes, so all pregnancy outcomes according to per-protocol analysis are shown in Table 4 . Among the study participants, 33 (4.6%) developed ovarian hyperstimulation, 18 from the cervical-mucusremoval group and 15 from the non-mucus-removal group. All but one case were of a mild type that required only outpatient monitoring, while the one (from the mucusremoval group) who had moderate ovarian hyperstimulation required hospitalization for three days. Pregnancy was not recorded in any of these cases.
Discussion

Main findings
The results of the present study show that removal of the cervical mucus from the internal and external cervical os before IUI can improve pregnancy outcomes in women with unexplained infertility. The exact mechanism by which cervical mucus removal can enhance pregnancy outcomes is still insufficiently studied, but once this mucus is present, especially if abundant, it may: cause failure of insemination by reducing release of sperm from the catheter; 14 interfere with sperm-oocyte interaction; 8 or push possibly contaminated mucus into the uterine cavity where it may either kill the newly formed embryos 15 or hinder their attachment to the endometrium by stimulating uterine contractions. 8 
Strengths and limitations
Several points add strength to our study: (1) it was prospective, randomized, conducted according to the CONSORT guidelines, and both the intention-to-treat and per-protocol analyses are reported; (2) homogeneity among the study groups makes the difference in their pregnancy rates totally dependent on the cervical mucus factor; (3) couples for whom cervical mucus may be a factor in their infertility (unexplained) were the candidates for the study; (4) each couple was involved once to eliminate any bias resulting from subjects undergoing repeat cycles as this could enhance their pregnancy outcomes; (5) participants were followed up until delivery; and (6) difficulty during IUI performance was recorded for both groups.
Some limitations could not be avoided, however: (1) women with actual hostile cervical mucus were not identified by performing a post-coital test, something of particular importance in women with unexplained infertility, but with no essential role during infertility work-up; (2) only women with unexplained infertility were involved even though IUI could be used to treat different infertility indications; (3) the rate of catheter bacterial contamination was not determined; (4) the outcomes were not compared when using the procedure alone or combined with cervical irrigation; and (5) only the patients were blinded during the study, while doctors knew group assignments. Although this can be avoided in the future by allocating a nurse to perform the mucus manipulation, this did not affect our results as the study outcomes were objective, so bias was not possible.
Interpretation
While IUI is perhaps used less than it once was, it is still a very useful and desirable treatment option for unexplained infertility. Previous studies are in line with our findings confirming the role of this non-invasive and cheap procedure in improving clinical pregnancy rates in these patients, but most earlier studies were of low quality because of improper randomization, and most explored the role of the procedure in IVF cycles. When considering cervical mucus aspiration before IUI, Simsek et al. 8 found it to be associated with improved pregnancy outcomes (24% in the mucus-aspiration group versus 9.5% in the non-aspiration group, P = 0.04). In their randomized trial, Ghasemi et al. 16 reported a clinical pregnancy rate of 14.2% among cases of unexplained infertility who underwent mucus removal before insemination (P = 0.04; OR, 2.199; CI 95%, 0.997-4.85). Azmodeh et al. 17 reported a pregnancy rate of 14.3% in the cervicalmucus-removal group, which was statistically significantly more than in the control group (10.3%); the same was reported by Abdallah et al. 13 [pregnancy rates of 18 and 8% in the mucus-removal and non-mucus-removal groups, respectively (P = 0.05)].
The role of the procedure was much more evident before embryo transfer during intracytoplasmic sperm injection (ICSI) cycles. Moini et al. 18 reported a clinical pregnancy rate of 39.2% in the intervention group compared with 22.6% in the control group (P <0.001; OR, 2.297; CI 95%, 1.552-3.399), while another two studies 19, 20 reported a similar increase in pregnancy rates when they removed the mucus by cytobrush followed by vigorous cervical canal irrigation. Eskander et al. 9 also found a 2.18-fold increase in pregnancy rates with cervical mucus aspiration prior to embryo transfer.
In spite of these reports, some authors rejected any role for the procedure because touching the cervix and endocervix might stimulate uterine contractions, which has been suggested to cause a reduction in pregnancy rates. 21, 22 Another disadvantage of the procedure is difficulty during embryo transfer resulting from the absence of the lubricating effect of cervical mucus that could increase the percent of retained embryos, although other factors such as cervical bleeding and contamination of the catheter tip with blood may have a role. 9, 23 Other authors cited the role of cervical mucus in enhancing pregnancy by increasing the number of sperm introduced into the uterine cavity by acting as a barrier preventing sperm leakage into the vagina after deposition. 8 Yet other authors 9 considered IUI to be a time-consuming procedure because of the time taken up by the procedure itself together with at least another 5-10 minutes to allow the uterus to become quiescent, all of which could be cumbersome, especially in busy IVF units.
There is no agreement in the studies regarding the cervical mucus technique and whether it should be performed alone or combined with cervical irrigation. Some recommended only cervical mucus cleaning as it is easily performed, cheap, and less invasive, 24 while others used catheter aspiration for complete mucus removal. 25 Berjis et al. 24 removed cervical mucus in a rotatory fashion, using three to five swabs wetted with normal saline, while others removed it using swabs wetted with Ringer lactate solution as they supposed this to have less effect on spermatozoid osmolality. 26 One group 22 removed the cervical mucus by cervical brush, while some groups reported their pregnancy rates when cervical irrigation was combined with cervical mucus removal by aspiration. 27, 28 In our study, we did not practice cervical irrigation after mucus aspiration since a systematic review 29 showed no improved pregnancy rates when cervical irrigation followed mucus aspiration.
The overall clinical pregnancy rate in this study was 26.5%. This rate is high, approaching that of IVF. There is a wide range in the pregnancy rate in IUI cycles: a meta-analysis reported the pregnancy rate per IUI cycle ranged between 6 and 22%, 3 and in one report, a rate of 35% was noted after a single cycle. 30 The higher rates in our study can be explained by our inclusion criteria: younger age group (all except two were 35 years or less) with well-functioning ovaries, a diagnosis of unexplained infertility (maximum benefit from IUI), and husbands with good quality seminograms.
We have pursued the intention-to-treat principle for analysis of our treatment groups. This involves all participants once randomly allocated to avoid any bias. By contrast, using per-protocol analysis, which compares only those members of treatment groups who complete their treatment, leads to bias. 31 We report all planned outcomes in relation to both analyses to accurately interpret the effect of our intervention.
Conclusion
Our results show that cervical mucus removal prior to IUI can enhance pregnancy outcomes in women with unexplained infertility, but these results require confirmation with additional randomized trials. The low number of studies so far performed indicates there is a genuine shortage of published evidence supporting the procedure.
Disclosure of interests
None declared. Completed disclosure of interests form available to view online as supporting information.
Contribution to authorship
MAM, TMS, and NE developed the hypothesis. TMS and NE collected the data, performed the analyses, and were involved in the care of the women. MAM was primarily responsible for writing the manuscript. All authors contributed to the interpretation of the data and preparation of the manuscript.
Details of ethics approval
This study was approved by the ethics committee at Menoufia University Hospitals, Shebin El-Kom, Egypt (Ob/ Gyn protocols, August 2014). The study was also registered with the International Standard Randomised Controlled Trial Number ISRCTN87670645.
Funding
No funding was received for this paper.
